The Oncology Institute, Inc. (TOI)

The Oncology Institute Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	30.28	33.57	49.67	33.49	14.01	115.17
Short-Term Investments	-	-	-	49.37	59.8	-
Cash & Short-Term Investments	30.28	33.57	49.67	82.86	73.81	115.17
Cash Growth	-23.80%	-32.42%	-40.05%	12.26%	-35.92%	1820.21%
Accounts Receivable	58.13	59	48.34	42.36	39.82	20.01
Other Receivables	1.32	0.32	0.35	0.55	0.62	1.24
Total Trade Receivables	59.45	59.32	48.68	42.91	40.43	21.24
Inventory	-	16.88	10.04	13.68	9.26	6.44
Other Current Assets	2.84	2.99	4.03	4.05	6.92	11.2
Total Current Assets	92.57	112.75	112.42	143.49	130.42	154.06
Net Property, Plant & Equipment	33.22	33.06	37.67	40.05	33.04	4.19
Other Intangible Assets	10.3	11.02	14.81	17.9	17.96	18.25
Goodwill	7.23	7.23	7.23	7.23	21.42	26.63
Long-Term Investments	-	-	-	-	58.35	-
Other Long-Term Assets	0.62	0.61	0.59	0.56	0.48	0.32
Total Assets	143.94	164.66	172.72	209.24	261.67	203.44
Accounts Payable	47.65	43.17	24.32	14.43	9.37	15.56
Accrued Expenses	24.3	20.64	21.09	14	14.85	14.06
Current Portion of Long-Term Debt	-	-	-	-	-	0.18
Current Portion of Leases	7.4	7.16	6.8	6.36	5.5	-
Total Current Liabilities	79.35	70.96	52.22	34.79	29.72	29.8
Long-Term Debt	78.61	77.4	93.13	86.83	80.62	-
Long-Term Leases	18.84	19.13	23.22	26.49	22.06	-
Other Long-Term Liabilities	7.71	12.88	0.56	4.12	6.09	69.48
Total Long-Term Liabilities	105.16	109.41	116.91	117.43	108.77	69.48
Total Liabilities	184.52	180.38	169.13	152.22	138.49	99.28
Common Stock	0.01	0.01	0.01	0.01	0	0.01
Treasury Stock	-1.02	-1.02	-1.02	-1.02	-	-
Additional Paid-in Capital	258.64	256.71	215.41	204.19	186.25	167.39
Retained Earnings	-273.91	-271.42	-210.81	-146.15	-63.08	-63.23
Shareholders' Equity	-16.29	-15.72	3.59	57.03	123.17	104.16
Total Liabilities & Equity	168.23	164.66	172.72	209.24	261.67	203.44
Total Debt	104.86	103.69	123.15	119.68	108.18	0.18
Net Cash (Debt)	-74.58	-70.12	-73.48	-36.82	-34.37	114.99
Net Cash Per Share	-0.76	-0.76	-0.98	-0.50	-0.43	1.74
Book Value	-16.29	-15.72	3.59	57.03	123.17	104.16
Book Value Per Share	-0.17	-0.17	0.05	0.77	1.53	1.57
Tangible Book Value	-33.82	-33.97	-18.45	31.89	83.79	59.29
Tangible Book Value Per Share	-0.34	-0.37	-0.25	0.43	1.04	0.90

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q